Gail Colbern
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Equine top 5%
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 2
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Peter K. Working (8 shared papers)Michael Amantea (2 shared papers)John W. Park (5 shared papers)Christopher C. Benz (4 shared papers)Refaat Shalaby (4 shared papers)Demetrios Papahadjopoulos (4 shared papers)Keelung Hong (4 shared papers)Dmitri B. Kirpotin (4 shared papers)
- Journals
- Journal of Liposome Research (4 papers)Journal of Equine Veterinary Science (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Clinical Cancer Research (2 papers)American Journal of Obstetrics and Gynecology (2 papers)
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
Gail Colbern
20 papers receiving 1.4k citations
Gail Colbern's Hit Papers
Peers
Comparison fields: 5 of 94
- Biomaterials 738
- Equine 29
- Oncology 275
- Pharmaceutical Science 62
- Molecular Biology 645
Countries citing papers authored by Gail Colbern
This map shows the geographic impact of Gail Colbern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Colbern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Colbern more than expected).
Fields of papers citing papers by Gail Colbern
This network shows the impact of papers produced by Gail Colbern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Colbern. The network helps show where Gail Colbern may publish in the future.
Co-authors
The 25 scholars most cited alongside Gail Colbern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Hit paper breakdown → | 2002 | 519 |
| 2 | 1999 | 240 | |
| 3 | 2004 | 153 | |
| 4 | 2004 | 133 | |
| 5 | 1994 | 86 | |
| 6 | 2002 | 69 | |
| 7 | 2004 | 60 | |
| 8 | 1999 | 40 | |
| 9 | 1999 | 25 | |
| 10 | 1997 | 24 | |
| 11 | 2005 | 22 | |
| 12 | 1994 | 16 | |
| 13 | 1998 | 15 | |
| 14 | 1987 | 14 | |
| 15 | Anti-HER2 Immunoliposomes | 2002 | 10 |
| 16 | 1987 | 9 | |
| 17 | 1987 | 7 | |
| 18 | 2000 | 6 | |
| 19 | 1984 | 5 | |
| 20 | IAP (inhibitor of apoptosis) antagonist inhibits orthotopic lung tumor growth | 2007 | 1 |
About Gail Colbern
Gail Colbern is a scholar working on Oncology, Biomaterials, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Equine, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Veterinary Equine Medical Research (4 papers), Reproductive System and Pregnancy (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Reproductive Physiology in Livestock (3 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Research Studies (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Biomaterials (738 citations), Equine (29 citations), Oncology (275 citations), Pharmaceutical Science (62 citations) and Molecular Biology (645 citations). Gail Colbern has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Peter K. Working, Michael Amantea, John W. Park, Christopher C. Benz, Refaat Shalaby, Demetrios Papahadjopoulos, Keelung Hong, Dmitri B. Kirpotin, Charles Engbers and Mary S. Newman. Their work appears in journals such as Journal of Liposome Research, Journal of Equine Veterinary Science, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research and American Journal of Obstetrics and Gynecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.